Q&A: What the Executive Order on Regulations Could Mean for EPA, FDA

A conversation with public health expert Lynn Goldman, a former assistant administrator at the US Environmental Protection Agency

Written byJoshua A. Krisch
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The headquarters of the United States Environmental Protection Agency in Washington, D.CWIKIMEDIA, COOLCAESERPresident Donald Trump signed an executive order on January 30, requiring that federal agencies repeal two regulations for every new one they propose. In a statement, Rick Pollack, chief executive officer of the American Hospital Association, praised the order as a step toward removing “red tape” that can drive up health care costs. Meanwhile, Joan Claybrook, former head of the National Highway Traffic Safety Administration, had a decidedly less optimistic reaction. “People are going to die if you start eliminating safety standards,” she told the Los Angeles Times.

Lynn Goldman, dean of the George Washington University Milken Institute School of Public Health and a former assistant administrator for the Environmental Protection Agency (EPA)’s Office of Chemical Safety and Pollution Prevention, spoke with The Scientist about the executive order, and the impact it may have on federal agencies including the EPA and the Food and Drug Administration (FDA).

The Scientist: What do you think was President Trump’s goal in issuing this order?

Lynn Goldman: I think his intent is to follow through on a commitment made in the campaign to reduce regulation, and I believe there was then a verbal commitment that, for every regulation issued, two would be eliminated. And, overall, there are many supporters of the president who sense the importance of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series